NirvanamKnowledge · Cases · Solver

Peptide or Protein

Ipilimumab

AMW:CHEM:120823

An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.

Biochemistry biochemical

Graph assertions

Embed this node